Should I Buy THAR? THAR 2026 Analysis

Should You Buy Tharimmune Inc (THAR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

4.470

1 Day change

10.37%

52 Week Range

9.080

Analysis Updated At

2026/01/26

Tharimmune Inc (THAR) is not a strong buy for a beginner, long-term investor at this moment. Despite insider buying activity and a pre-market price increase, the company's weak financial performance, lack of strong technical signals, and the potential dilution from the recent offering make it a less attractive investment currently. Holding off for clearer signs of growth or stability is recommended.

Technical Analysis

The technical indicators are neutral to slightly bearish. The MACD is below zero and contracting negatively, the RSI is neutral at 52.508, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 2.91, with resistance at 3.055 and support at 2.765.

Options Data

Positive Catalysts

Insider buying has surged by 5974.89% over the last month, indicating potential confidence from insiders. The pre-market price is up 4.39%, suggesting short-term positive sentiment.

Neutral/Negative Catalysts

The company announced a $55 million registered offering, which could dilute existing shares. Financial performance in Q3 2025 was weak, with a significant drop in net income (-44.63% YoY) and EPS (-86.12% YoY). The stock has a 40% chance of declining in the next day and week based on similar candlestick patterns.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth, net income dropped to -$2,101,838 (-44.63% YoY), and EPS fell to -0.34 (-86.12% YoY). Gross margin also showed no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes were provided for this stock.

Analyst Rating

Wall Street analysts forecast THAR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THAR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 4.050

Low

Averages

High